BATF2 expression had significant associations with clinical stage (p = 0.040), recurrence (p = 0.000), and Ki-67 expression (a prognostic biomarker) in NPC (Figure 1C; Table 2). The gene discussed is BATF2; the disease is nasopharyngeal carcinoma.